rejoin
Generic: autologous haMPC
rejoin: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. (CMBG) | Phase 2 |
Get deeper analysis on rejoin
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis